Hoefig CS, Renko K, Kohrle J, Birringer M, Schomburg L

Comparison of different selenocompounds with respect to nutritional value vs. toxicity using liver cells in culture.

J Nutr Biochem 22:945-55 (2011)
DOI:10.1016/j.jnutbio.2010.08.006

McKenzie MJ, Hunter DA, Pathirana R, Watson LM, Joyce NI, Matich AJ, Rowan DD, Brummell DA

Accumulation of an organic anticancer selenium compound in a transgenic Solanaceous species shows wider applicability of the selenocysteine methyltransferase transgene from selenium hyperaccumulators.

Transgenic Res 18:407-24 (2009)
DOI:10.1007/s11248-008-9233-0

Pinto JT, Lee JI, Sinha R, MacEwan ME, Cooper AJ

Chemopreventive mechanisms of alpha-keto acid metabolites of naturally occurring organoselenium compounds.

Amino Acids 41:29-41 (2011)
DOI:10.1007/s00726-010-0578-3

Suzuki KT, Kurasaki K, Suzuki N

Selenocysteine beta-lyase and methylselenol demethylase in the metabolism of Se-methylated selenocompounds into selenide.

Biochim Biophys Acta 1770:1053-61 (2007)
DOI:10.1016/j.bbagen.2007.03.007

Gromer S, Gross JH

Methylseleninate is a substrate rather than an inhibitor of mammalian thioredoxin reductase. Implications for the antitumor effects of selenium.

J Biol Chem 277:9701-6 (2002)
DOI:10.1074/jbc.M109234200